Search

everythinglearnresearchcommunity

for

Search:↓

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Post-finasteride syndrome is rare but serious and should be taken seriously.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Targeting specific genes in certain pathways may help treat male pattern baldness.

Enzymes play crucial roles in metabolism, health, and disease management.

Compound 4 is a promising treatment for hair loss with low toxicity.

An 80-year-old man grew extra hair on his forearms after starting Alzheimer's medication rivastigmine.

New treatments for male hypogonadism are effective and should be personalized.

New alopecia treatments aim for better results and fewer side effects.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Finasteride may cause slight depression and anxiety.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Finasteride effectively treats male hair loss, improving growth and density.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Lovastatin doesn't improve lower urinary tract symptoms treatment.